RecruitingNCT07348341

Coronary Laser Atherectomy Registry From an International Taskforce


Sponsor

Ceric Sàrl

Enrollment

500 participants

Start Date

Jul 20, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This study is a prospective, investigator-initiated, multi-center, single arm, observational registry of performance of Excimer Laser Coronary Atherectomy (ELCA) in standard use cases of percutaneous coronary intervention (PCI).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Excimer Laser Coronary Atherectomy (ELCA) for people with acute coronary syndromes and stable coronary artery disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEExcimer Laser Coronary Atherectomy (ELCA)

ELCA treat a significant coronary stenosis or recanalize occluded coronary arteries using UV during percutaneous coronary intervention.


Locations(1)

La Paz Universtity Hospital

Madrid, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07348341


Related Trials